Sunitinib Combined with Th1 Cytokines Potentiates Apoptosis in Human Breast Cancer Cells and Suppresses Tumor Growth in a Murine Model of HER-2pos Breast Cancer

Although immune-based therapies have made remarkable inroads in cancer treatment, they usually must be combined with standard treatment modalities, including cytotoxic drugs, to achieve maximal clinical benefits. As immunotherapies are further advanced and refined, considerable efforts will be requi...

Full description

Bibliographic Details
Main Authors: Nirmala Ghimirey, Chase Steele, Brian J. Czerniecki, Gary K. Koski, Loral E. Showalter
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:International Journal of Breast Cancer
Online Access:http://dx.doi.org/10.1155/2021/8818393

Similar Items